Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Breo Ellipta (fluticasone/vilanterol) and Advair (fluticasone/salmeterol) are both combination inhalers used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). They belong to the same medication class, combining an inhaled corticosteroid (ICS) with a long-acting beta agonist (LABA). However, there are several differences between them. Breo Ellipta is typically taken once daily, while Advair is taken twice daily. Breo Ellipta is available in three strengths, but its generic form is available in only two strengths. Advair comes in two forms: Advair Diskus and Advair HFA, with different strengths for each. Both medications are available as a lower-cost generic. Common side effects for both medications include upper respiratory tract infections and headaches, but Advair users may also experience sore throat and nausea more frequently.
Breo ellipta (fluticasone furoate / vilanterol)
Advair (fluticasone / salmeterol)
Breo ellipta (fluticasone furoate / vilanterol)
Advair (fluticasone / salmeterol)
Summary of Breo Ellipta vs. Advair
Summary for Inhaled corticosteroid / LABA
Prescription only
Breo Ellipta (fluticasone furoate / vilanterol) is a maintenance inhaler used every day to help manage asthma and chronic obstructive pulmonary disease (COPD). It's a combination of two medications: fluticasone, a corticosteroid that reduces swelling in your lungs, and vilanterol, a long-acting beta agonist (LABA) that helps relax your airways. The typical dose is one puff by mouth once a day. Breo Ellipta (fluticasone furoate / vilanterol) isn't for sudden breathing problems or asthma attacks. Side effects include oral thrush, sore throat, and headache.